about
Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patientsTrends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based SurveillanceFactors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care HospitalTuberculosis and diabetes in southern Mexico.Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study.Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitalsRole of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistanceResults of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in MexicoGlobal phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP seTransmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.Prevalence of latent and active tuberculosis among dairy farm workers exposed to cattle infected by Mycobacterium bovis.Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012.Epidemiology of Invasive Fungal Infections in Latin America.Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin.Tuberculosis in ageing: high rates, complex diagnosis and poor clinical outcomesOutbreak caused by Enterobacteriaceae harboring NDM-1 metallo-β-lactamase carried in an IncFII plasmid in a tertiary care hospital in Mexico City.Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000-2015.Impact of cigarette smoking on rates and clinical prognosis of pulmonary tuberculosis in Southern Mexico.Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes.First case of Nocardia amamiensis pulmonary infection in Mexico.Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay.High prevalence of Chlamydia pneumoniae seropositivity in Mexican patients with ischemic heart disease.The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship-results from an international cross-sectional survey.Molecular analysis of Mycobacterium tuberculosis strains with an intact pks15/1 gene in a rural community of Mexico.Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis.Identification and susceptibility testing of Candida spp. directly from yeast-positive blood cultures with Vitek 2.Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case-control-control study.Impact of Clostridium difficile infection caused by the NAP1/RT027 strain in severity and recurrence during an outbreak and transition to endemicity in a Mexican Tertiary Care Center.Cefepime versus ceftazidime for the treatment of serious bacterial infections.Comparison of sodium carbonate, cetyl-pyridinium chloride, and sodium borate for preservation of sputa for culture of Mycobacterium tuberculosis.Risk factors for drug-resistant bloodstream infections in patients with systemic lupus erythematosus.Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis.Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.Raising concerns about the Sepsis-3 definitions.[Active tuberculosis in a cohort of HIV-infected inmates in a prison in Mexico City: clinical and epidemiological characteristics].Does DOTS work in populations with drug-resistant tuberculosis?
P50
Q28468519-EDFAADA0-E55D-4BC9-87F9-AB11DFC456F2Q28482730-FAC5DCAC-9516-415B-9365-CEC066D4316BQ28548636-ABD03696-6FE5-459A-BE77-899BA292A3E1Q28550029-BBA434D2-E0F0-41AE-96E6-83412938700DQ29013727-8433D3BC-0F3D-4E4E-BD5B-060C51A4886DQ30840887-65B7FFCB-666B-41B0-8C5F-518998EDF0ABQ33443585-90EFF91E-23B0-41C0-A679-EFC86D3EED47Q33618418-15716CB8-70C8-409B-BF60-3BB470C78C89Q33935393-AD562A52-40D9-47A0-99E3-726BF4879202Q34206649-EEDB04C3-428B-41C1-9EC0-443B649A2859Q34303290-C60AEAF4-B772-4C6F-94D0-9557FCDF6EBDQ34492873-4C44C525-C1AC-4063-B5E4-AF4176F0E32AQ34702454-CDA1D138-5239-4476-9B72-9B203FF5AE75Q34973711-28716262-2DCE-41F8-A930-01E89C8E0993Q35663649-EDD74C5F-C449-483B-AE1E-6EF575141A7DQ35751864-0DAF54C2-A400-4C4B-B055-7001E7D9A0DFQ35913637-5E7ABEFC-F9FC-41BA-A2CA-81C412669413Q36038925-7B35E679-D53B-4278-9E30-4A4B0FCBE6E9Q36158228-1C6CD10A-A39F-495B-BE57-E7C3D568927BQ36185986-BF8D99AA-5270-49F3-A102-7CC0BABC1D8EQ36527513-0A563C06-C96A-43CB-BF54-B0A18BDD63C8Q36648076-9E1D475C-1158-441C-BEDE-43FB75473DAAQ37578514-6422AAD8-9C6E-4895-8FE3-2B7759B712C7Q37702801-15D913FC-7FF3-4CEC-BC37-9213630EBE1CQ37866592-DAD34C21-40C7-4E3A-A660-726A1F7F98D8Q38849402-451A273C-818D-4D69-9C26-4B2B2538D37FQ39861783-B65D1AA1-DD44-461A-8B4B-49861F325792Q40043410-63A2BC5C-073C-4C24-857E-05B7B6181552Q40089479-562E1870-54E1-4D09-BF33-F4423E15BC42Q40157393-EF191411-9759-496F-A2B6-9EE3096211F0Q40577799-B078EFB0-1CA4-46D8-83AB-D2C08B8ED6E0Q41922595-233664FD-E514-40A1-A5C3-3D45041A774FQ42618699-9B8D2668-4FB3-4E1C-A796-97561A93FA37Q42940475-59841B97-84A0-4157-81B2-D76828AC7564Q45741582-DAD62A61-FF1E-48E1-B59D-D804109F92D8Q46246635-38BFE451-EA4B-400E-BED0-83D5A82EF87EQ46568426-F7726B38-C63A-40D9-870D-D76758E58A19Q49416865-DA822773-ECF1-4EF2-88D1-32585DF62AD2Q53854699-1AFB26F8-16DF-4F64-BC1D-74DF588F7C46Q53861882-8EA2EB91-CEBD-46EF-A7C3-C9EF1CD2910E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alfredo Ponce-de-Leon
@ast
Alfredo Ponce-de-Leon
@en
Alfredo Ponce-de-Leon
@es
Alfredo Ponce-de-Leon
@nl
type
label
Alfredo Ponce-de-Leon
@ast
Alfredo Ponce-de-Leon
@en
Alfredo Ponce-de-Leon
@es
Alfredo Ponce-de-Leon
@nl
prefLabel
Alfredo Ponce-de-Leon
@ast
Alfredo Ponce-de-Leon
@en
Alfredo Ponce-de-Leon
@es
Alfredo Ponce-de-Leon
@nl
P106
P1153
7003924320
P21
P31
P496
0000-0003-2640-2916